Please login to the form below

Not currently logged in
Email:
Password:

immunisation

This page shows the latest immunisation news and features for those working in and with pharma, biotech and healthcare.

First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%

First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%

We will see much more data over the coming weeks and months but we should be very encouraged by these initial findings,” said Mary Ramsay, head of immunisation at PHE.

Latest news

More from news
Approximately 1 fully matching, plus 140 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • New faces at 90TEN, Lucid Group and Porterhouse New faces at 90TEN, Lucid Group and Porterhouse

    In that role, Cook delivered initiatives to improve national health, including promoting responsible antibiotic use, protecting against STIs and encouraging rates of childhood immunisation.

  • Burson-Marsteller hires senior DH press officer Burson-Marsteller hires senior DH press officer

    In her previous role, Moore worked with both public health ministers and the chief medical officer, developing proactive and reactive communications strategies for issues including immunisation, genetics, obesity and alcohol.

  • Kane & Finkel announces new European director

    In addition, as director of communications for the UK's Health Education Authority, he also developed public health campaigns for AIDS, smoking cessation, childhood immunisation and heart disease.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • The UK has approved the first vaccine for COVID-19. What now? The UK has approved the first vaccine for COVID-19. What now?

    by Glen Halliwell, Business Unit Director, Langland. The Joint Committee on Vaccination and Immunisation has quickly answered the first question regarding the priority vaccination groups for phase one. ... hesitation. The challenge of rolling out a brand

  • Is the world ready for a COVID-19 vaccine? Is the world ready for a COVID-19 vaccine?

    the help of local organisations, manage the roll out of routine immunisations every day. ... challenges for countries and states that do not have immunisation registries or ways of tracking patients.

  • UK vs US: what makes a successful immunisation programme?

    Before discussing these, let’s have a look at how immunisation uptake differs between the two countries. ... In the US this is The American Committee on Immunization Practices (ACIP) and in the UK it is the Joint Committee for Vaccination and

  • 90TEN makes senior hire from Public Health England

    In this role Clare delivered high profile initiatives to improve the nation’s health, including championing responsible antibiotics use, protecting against STIs and boosting rates of childhood immunisation.

  • Infographic: The vaccine opportunity in Asia 2019

    A rising demand for better healthcare infrastructure and high awareness levels of the benefits of immunisation are the major factors boosting the vaccine market growth. ... For World Immunisation Week 2019 we have updated one of our most popular

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics